SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012063
Filing Date
2024-08-13
Accepted
2024-08-13 16:30:43
Documents
98
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fbio-20240630x10q.htm   iXBRL 10-Q 3951176
2 EX-31.1 fbio-20240630xex31d1.htm EX-31.1 13882
3 EX-31.2 fbio-20240630xex31d2.htm EX-31.2 14566
4 EX-32.1 fbio-20240630xex32d1.htm EX-32.1 8182
5 EX-32.2 fbio-20240630xex32d2.htm EX-32.2 8119
  Complete submission text file 0001558370-24-012063.txt   14784357

Data Files

Seq Description Document Type Size
6 EX-101.SCH fbio-20240630.xsd EX-101.SCH 109161
7 EX-101.CAL fbio-20240630_cal.xml EX-101.CAL 89901
8 EX-101.DEF fbio-20240630_def.xml EX-101.DEF 432672
9 EX-101.LAB fbio-20240630_lab.xml EX-101.LAB 768031
10 EX-101.PRE fbio-20240630_pre.xml EX-101.PRE 632280
101 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20240630x10q_htm.xml XML 2611278
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 241202164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)